CN108478697A - A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung - Google Patents
A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung Download PDFInfo
- Publication number
- CN108478697A CN108478697A CN201810560925.XA CN201810560925A CN108478697A CN 108478697 A CN108478697 A CN 108478697A CN 201810560925 A CN201810560925 A CN 201810560925A CN 108478697 A CN108478697 A CN 108478697A
- Authority
- CN
- China
- Prior art keywords
- radix
- lung
- chronic obstructive
- chinese medicine
- obstructive disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 230000001684 chronic effect Effects 0.000 title claims abstract description 32
- 208000019693 Lung disease Diseases 0.000 title claims abstract description 31
- 230000000414 obstructive effect Effects 0.000 title claims abstract description 31
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 12
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 12
- 241000208671 Campanulaceae Species 0.000 claims abstract description 12
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 12
- 239000000654 additive Substances 0.000 claims abstract description 12
- 235000020224 almond Nutrition 0.000 claims abstract description 12
- 241000489492 Arisaema Species 0.000 claims abstract description 10
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 10
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 10
- 241000756943 Codonopsis Species 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- 210000000941 bile Anatomy 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 8
- 230000035622 drinking Effects 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 2
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000004199 lung function Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- PECIYKGSSMCNHN-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=NC=N[C]21.O=C1N(C)C(=O)N(C)C2=NC=N[C]21 PECIYKGSSMCNHN-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003153 cholinolytic effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a kind of Chinese medicine preparations, a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung are particularly related to, including following drug component and/or pharmaceutically acceptable additives：Earthworm, almond, campanulaceae, arisaema cum bile, Radix Angelicae Sinensis, Radix Codonopsis, Radix Astragali, pollen, Radix Glehniae, radix scutellariae, wild chrysanthemum, radix bupleuri, rhizoma alismatis, bulbus fritillariae cirrhosae, rhizoma atractylodis macrocephalae, Radix Glycyrrhizae.A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung of the present invention, has effects that nourishiing yin to clear away the lung-heat, clearing heat and detoxicating, blood circulation and channel invigorating；It can effectively improve immunity, enhancing lung function metabolism simultaneously.A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung of the present invention, is mainly used for treating chronic obstructive disease of lung, while also particularly good to four seasons common cold curative effect.The course for the treatment of is 15 days when being treated for chronic obstructive disease of lung, and it is 35 days to be used for course for the treatment of when common cold treatment.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparations, and prescription is configured more particularly to a kind of Chinese medicine for treating chronic obstructive disease of lung.
Background technology
Chronic obstructive disease of lung, that is, Chronic Obstructive Pulmonary Disease, with the characteristics of not fully reversible flow limitation.Chronic obstructive disease of lung air-flow
It is limited often to be aggravated in progressive, and with to deleterious particle or gas, mainly the pulmonary abnormalities inflammatory reaction of caused by smoking.Though
Right chronic obstructive pulmonary disease directly involves lung, but can also cause significant systemic effect.
Chronic obstructive pulmonary disease case fatality rate is high；With shortness of breath, expectoration, pants and aggravate repeatedly；Not only damage air flue, alveolar and lung blood
Pipe, while also being organized outside damage lung, such as bone, skeletal muscle, heart and other organs；It is a polygenic systemic disease
Disease.Its clinical manifestation, the course of disease and there is prodigious individual difference to the therapeutic response etc. of drug.
Chronic Obstructive Pulmonary Disease disability rate and case fatality rate are very high, and 40 years old global or more incidence has been up to 9%~10%.
The 4th of the global cause of death in disease residence at present, the World Bank/World Health Organization announces, and chronic obstructive pulmonary disease will occupy to 2020
The 5th of world's disease financial burden.In China, chronic obstructive pulmonary disease is equally the important chronic respiratory for seriously endangering people's health
Systemic disease, case fatality rate is up to 0.46% or so.
Chronic obstructive pulmonary disease is since its number of patients is more, and the death rate is high, social economical burden weight, it has also become one important public to defend
Raw problem, there is no radical cure method so far.Chronic obstructive pulmonary disease is with chronic cough, expectoration, with the characteristics of shortness of breath or expiratory dyspnea.Chronic obstructive pulmonary disease is controlled
It treats and mainly mitigates symptom, prevents progression of the disease, alleviate or prevent decline in pulmonary function, improve mobility, improve the quality of living,
For the purpose of reduction case fatality rate.For chronic obstructive disease of lung since pathogenesis not yet illustrates completely, making traditional Chinese and western medicine in the treatment has very big limitation
Property.Chinese medicine generally using resolving sputum drink, the method for cough-relieving asthma and strengthening spleen, tonifying kidney, mostly uses erchen tang, Xiao Qinglong Tang, chinkuei shin chewan pills
Deng but curative effect is of short duration, and cure rate is low and easy recurrence；Doctor trained in Western medicine is just for sensibiligen, allergy parasexuality and the clinical condition showed
Shape, the method that use is anti-inflammatory, antiallergic and spasmolysis are relievingd asthma use aminophylline, beta receptor excitant, cholinolytic class, steroids and medium
The drugs such as release retardance class；It can only temporarily alleviate the symptoms, due to that cannot effect a radical cure, make patient have to take for a long time, to cause
The side effects such as hormone dependant, obesity, endocrine disturbance.
Invention content
In view of the existing problems, the present invention provides a kind of safe, high efficiency, are suitable for various card types
The Chinese medicine for treating chronic obstructive disease of lung configures prescription.
The present invention is achieved by the following technical solutions：
A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung, including following drug component and/or pharmaceutically acceptable
Additives：Earthworm, almond, campanulaceae, arisaema cum bile, Radix Angelicae Sinensis, Radix Codonopsis, Radix Astragali, pollen, Radix Glehniae, radix scutellariae, wild chrysanthemum, radix bupleuri, pool
Rush down, bulbus fritillariae cirrhosae, rhizoma atractylodis macrocephalae, Radix Glycyrrhizae.
Further embodiment is made of the drug and/or pharmaceutically acceptable additives of following parts by weight：Earthworm 5%-
10%, almond 6%-9%, campanulaceae 2%-7%, arisaema cum bile 4%-8%, Radix Angelicae Sinensis 5%-9%, Radix Codonopsis 3%-8%, Radix Astragali 4%-
7%, pollen 1%-7%, Radix Glehniae 2%-8%, radix scutellariae 4%-10%, wild chrysanthemum 3%-7%, radix bupleuri 4%-8%, rhizoma alismatis 5%-
10%, bulbus fritillariae cirrhosae 5%-8%, rhizoma atractylodis macrocephalae 4%-7%, Radix Glycyrrhizae 2%-6%.
Further embodiment, the drug of preferably following parts by weight and/or pharmaceutically acceptable additives composition：Earthworm
6%-8%, almond 6%-8%, campanulaceae 4%-6%, arisaema cum bile 5%-7%, Radix Angelicae Sinensis 6%-7%, Radix Codonopsis 5%-7%, Radix Astragali
6%-7%, pollen 5%-7%, Radix Glehniae 4%-7%, radix scutellariae 6%-8%, wild chrysanthemum 6%-7%, radix bupleuri 6%-8%, rhizoma alismatis
5%-8%, bulbus fritillariae cirrhosae 6%-7%, rhizoma atractylodis macrocephalae 4%-7%, Radix Glycyrrhizae 4%-6%.
Further embodiment, the drug of preferably following parts by weight and/or pharmaceutically acceptable additives composition：Earthworm
6.2%-7%, almond 6%-6.8%, campanulaceae 4.5%-5.5%, Radix Glehniae 5.2%-6.5%, radix scutellariae 6%-6.8%, mother chrysanthemum
Flower 6%-6.5%, radix bupleuri 6%-7%, rhizoma alismatis 5%-6.5%, bulbus fritillariae cirrhosae 6%-6.6%, rhizoma atractylodis macrocephalae 5.2%-6.2%, Radix Glycyrrhizae
4.5%-5.2%.
Further embodiment, application method are：By every pair of Chinese medicine 250-350g of total weight, 2-3L water is added to decoct 2-3
Secondary, each 45-75min, collecting decoction is concentrated into 250-300ml and drinks.
Further embodiment, the concentrated medicament are enclosed in 0-4 DEG C and preserve 3-5 days, and fluid temperature is not low when drinking
In 30 DEG C.
A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung of the present invention, is mainly used for treating chronic obstructive disease of lung, simultaneously
It is also particularly good to four seasons common cold curative effect.The course for the treatment of is 15 days when being treated for chronic obstructive disease of lung, and it is 3-5 days to be used for course for the treatment of when common cold treatment.
Advantageous effect：
1. a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung of the present invention, has nourishiing yin to clear away the lung-heat, clearing heat and detoxicating, living
The effect of blood is promoted blood circulation.
2. a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung of the present invention, can effectively improve immunity, enhances
Lung function is metabolized.
Specific implementation mode
In order to make the foregoing objectives, features and advantages of the present invention clearer and more comprehensible, below to the specific reality of the present invention
The mode of applying elaborates.Many details are elaborated in the following description in order to fully understand the present invention.But this
Invention can be much to implement different from other manner described here, and those skilled in the art can be without prejudice to the present invention
Similar improvement is done in the case of intension, therefore the present invention is not limited by following public specific implementation mode.
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung, including following drug component and/or pharmaceutically acceptable
Additives：Earthworm 6.5%, almond 6.5%, campanulaceae 5.5%, arisaema cum bile 6.5%, Radix Angelicae Sinensis 7%, Radix Codonopsis 7%, Radix Astragali 7%, flower
Powder 6%, Radix Glehniae 6%, radix scutellariae 8%, wild chrysanthemum 7%, radix bupleuri 6%, rhizoma alismatis 6%, bulbus fritillariae cirrhosae 6%, rhizoma atractylodis macrocephalae 6%, Radix Glycyrrhizae
5%.
Further embodiment, application method are：By every pair of Chinese medicine total weight 300g, add 2.4L water decoction 3 times, every time
60min, collecting decoction are concentrated into 250ml and drink.
Further embodiment, the concentrated medicament are enclosed in 0-4 DEG C and preserve 3-5 days, and fluid temperature is not low when drinking
In 30 DEG C.
The Chinese medicine of the treatment chronic obstructive disease of lung of this programme tanning configures prescription, treatment chronic obstructive disease of lung 10-15 days, you can recovery from illness.
Embodiment 2
A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung, including following drug component and/or pharmaceutically acceptable
Additives：Earthworm 5%, almond 7%, campanulaceae 6%, arisaema cum bile 8%, Radix Angelicae Sinensis 8%, Radix Codonopsis 5%, Radix Astragali 6%, pollen 4%, north
The root of straight ladybell 5%, radix scutellariae 6%, wild chrysanthemum 6%, radix bupleuri 7%, rhizoma alismatis 8%, bulbus fritillariae cirrhosae 7%, rhizoma atractylodis macrocephalae 7%, Radix Glycyrrhizae 5%.
Further embodiment, application method are：By every pair of Chinese medicine total weight 250g, add 2.6L water decoction 2 times, every time
45min, collecting decoction are concentrated into 300ml and drink.
Further embodiment, the concentrated medicament are enclosed in 0-4 DEG C and preserve 3-5 days, and fluid temperature is not low when drinking
In 30 DEG C.
The Chinese medicine of this programme tanning configures prescription, treatment four seasons common cold 3-5 days, you can recovery from illness.
Embodiment 3
A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung, including following drug component and/or pharmaceutically acceptable
Additives：Earthworm 6.5%, almond 6.5%, campanulaceae 5%, arisaema cum bile 6.5%, Radix Angelicae Sinensis 6.5%, Radix Codonopsis 6.5%, Radix Astragali
6.5%, pollen 6.5%, Radix Glehniae 6.5%, radix scutellariae 7%, wild chrysanthemum 7%, radix bupleuri 6.5%, rhizoma alismatis 6.5%, bulbus fritillariae cirrhosae
6.5%, rhizoma atractylodis macrocephalae 6.5%, Radix Glycyrrhizae 3%.
Further embodiment, application method are：By every pair of Chinese medicine total weight 350g, add 3L water decoction 3 times, every time
75min, collecting decoction are concentrated into 300ml and drink.
Further embodiment, the concentrated medicament are enclosed in 0-4 DEG C and preserve 3-5 days, and fluid temperature is not low when drinking
In 30 DEG C.
The Chinese medicine of the treatment chronic obstructive disease of lung of this programme tanning configures prescription, treatment chronic obstructive disease of lung 10-15 days, you can recovery from illness.
Although hereinbefore having been made with reference to some embodiments, present invention is described, do not departing from the present invention's
In the case of range, it can be carried out various improvement and can use it is equivalent without replacement technology point therein, especially, as long as
There is no technical contradiction, the various features in the various embodiments of institute's careless mistake of the present invention can be combined by either type and be made
It is only in omitting length and economize on resources with, the description that the case where not combined in the present invention to these carries out exhaustive row
Consider.Therefore, the invention is not limited in specific embodiments disclosed herein, and include falling into claim.
Claims (6)
1. a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung, it is characterised in that, including following drug component and/or pharmacy
Upper acceptable additives：Earthworm, almond, campanulaceae, arisaema cum bile, Radix Angelicae Sinensis, Radix Codonopsis, Radix Astragali, pollen, Radix Glehniae, radix scutellariae, mother chrysanthemum
Flower, radix bupleuri, rhizoma alismatis, bulbus fritillariae cirrhosae, rhizoma atractylodis macrocephalae, Radix Glycyrrhizae.
2. a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung according to claim 1, it is characterised in that, by following
The drug of parts by weight and/or pharmaceutically acceptable additives composition：Earthworm 5%-10%, almond 6%-9%, campanulaceae 2%-
7%, arisaema cum bile 4%-8%, Radix Angelicae Sinensis 5%-9%, Radix Codonopsis 3%-8%, Radix Astragali 4%-7%, pollen 1%-7%, Radix Glehniae 2%-
8%, radix scutellariae 4%-10%, wild chrysanthemum 3%-7%, radix bupleuri 4%-8%, rhizoma alismatis 5%-10%, bulbus fritillariae cirrhosae 5%-8%, rhizoma atractylodis macrocephalae
4%-7%, Radix Glycyrrhizae 2%-6%.
3. it is according to claim 2 it is a kind of for treat chronic obstructive disease of lung Chinese medicine configuration prescription, it is characterised in that, preferably with
The drug of lower parts by weight and/or pharmaceutically acceptable additives composition：Earthworm 6%-8%, almond 6%-8%, campanulaceae 4%-
6%, arisaema cum bile 5%-7%, Radix Angelicae Sinensis 6%-7%, Radix Codonopsis 5%-7%, Radix Astragali 6%-7%, pollen 5%-7%, Radix Glehniae 4%-
7%, radix scutellariae 6%-8%, wild chrysanthemum 6%-7%, radix bupleuri 6%-8%, rhizoma alismatis 5%-8%, bulbus fritillariae cirrhosae 6%-7%, rhizoma atractylodis macrocephalae
4%-7%, Radix Glycyrrhizae 4%-6%.
4. it is according to claim 3 it is a kind of for treat chronic obstructive disease of lung Chinese medicine configuration prescription, it is characterised in that, preferably with
The drug of lower parts by weight and/or pharmaceutically acceptable additives composition：Earthworm 6.2%-7%, almond 6%-6.8%, campanulaceae
4.5%-5.5%, Radix Glehniae 5.2%-6.5%, radix scutellariae 6%-6.8%, wild chrysanthemum 6%-6.5%, radix bupleuri 6%-7%, rhizoma alismatis
5%-6.5%, bulbus fritillariae cirrhosae 6%-6.6%, rhizoma atractylodis macrocephalae 5.2%-6.2%, Radix Glycyrrhizae 4.5%-5.2%.
5. a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung according to claim 1, it is characterised in that, it uses
Method is：By every pair of Chinese medicine 250-350g of total weight, 2-3L water are added to decoct 2-3 times, each 45-75min, collecting decoction is dense
250-300ml is reduced to drink.
6. a kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung according to claim 5, it is characterised in that, it is described
Concentrated medicament is enclosed in 0-4 DEG C and preserves 3-5 days, and fluid temperature is not less than 30 DEG C when drinking.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810560925.XA CN108478697A (en) | 2018-05-25 | 2018-05-25 | A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810560925.XA CN108478697A (en) | 2018-05-25 | 2018-05-25 | A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108478697A true CN108478697A (en) | 2018-09-04 |
Family
ID=63341958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810560925.XA Pending CN108478697A (en) | 2018-05-25 | 2018-05-25 | A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108478697A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524158A (en) * | 2015-02-08 | 2015-04-22 | 长沙佰顺生物科技有限公司 | Pharmaceutical composition for treating chronic obstructive pulmonary disease |
| CN106552254A (en) * | 2015-09-30 | 2017-04-05 | 上海中医药大学附属曙光医院 | It is a kind of to treat Chinese medicine preparation of chronic obstructive pulmonary disease and preparation method thereof |
-
2018
- 2018-05-25 CN CN201810560925.XA patent/CN108478697A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524158A (en) * | 2015-02-08 | 2015-04-22 | 长沙佰顺生物科技有限公司 | Pharmaceutical composition for treating chronic obstructive pulmonary disease |
| CN106552254A (en) * | 2015-09-30 | 2017-04-05 | 上海中医药大学附属曙光医院 | It is a kind of to treat Chinese medicine preparation of chronic obstructive pulmonary disease and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 刘庆明: "健脾补肺汤治疗慢性阻塞性肺疾病稳定期45例", 《河南中医》 * |
| 郭燕蓉等: "益气活血法治疗慢性阻塞性肺疾病急性加重期兼气虚血瘀证30例", 《中国中医药现代远程教育》 * |
| 黄立搜等: "补肺益肾法对肺肾气虚型COPD稳定期患者免疫功能及白细胞介素13的影响", 《浙江中西医结合杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101143176A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN103550595B (en) | A kind of Chinese medicine oral liquid of heat-clearing and toxic substances removing | |
| CN106620391A (en) | Medicine for treating advanced non-small-cell lung cancer and preparation method of medicine | |
| CN1201793C (en) | Medicine composition for treatment of cough and asthma and preparation thereof | |
| CN104825944A (en) | Drug for treating blood-heat psoriasis and preparation method thereof | |
| CN103432563A (en) | Traditional Chinese medicine prescription for treating wind-cold type bronchial asthma | |
| CN103142857B (en) | Chinese medicinal granules for treating bronchitis combined emphysema and preparation method thereof | |
| CN108478697A (en) | A kind of Chinese medicine configuration prescription for treating chronic obstructive disease of lung | |
| CN104306793A (en) | Chinese herba preparation for treating lobar pneumonia | |
| CN102380075B (en) | Chinese medicine for treating child respiratory system infection and inflammation | |
| CN104069358A (en) | Chinese herba preparation for treating bronchial asthma | |
| CN101708303B (en) | Chinese medicinal composition for treating asthma | |
| CN102641425B (en) | Chinese herbal preparation for curing child acute pneumonia | |
| CN104474492A (en) | Traditional Chinese medicine composition for treating externally contracted wind evil and preparation method | |
| CN107693768A (en) | A kind of Chinese medicine preparation for treating asthma | |
| CN104027760A (en) | Traditional Chinese medicament for treating wind-phlegm in lung type asthma | |
| CN103330822B (en) | Chinese medicine formulation for curing chronic pharyngitis | |
| CN102861136A (en) | Medicament for treating pneumonia and preparation method thereof | |
| CN107496872A (en) | A kind of pill medicine for treating acute bronchitis in children and preparation method thereof | |
| CN107569655A (en) | A kind of Chinese medicine composition for acute exacerbation of chronic obstructive pulmonary disease | |
| CN103142872B (en) | Chinese medicine composition for treating wind-heat common cold | |
| CN106729364A (en) | A kind of Chinese medicine preparation for treating cirrhosis | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN100579565C (en) | Preparation for treating chronic pulmonary heart disease and preparation method thereof | |
| Wang et al. | Analysis on the traditional Chinese medicine syndromes and Six-Meridian Pattern Identification of coronavirus disease 2019 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180904 |
|
| RJ01 | Rejection of invention patent application after publication |